Compare $NRIX vs $VERA | Chartloom

Compare

$NRIX vs $VERA

Nurix Therapeutics Inc · Vera Therapeutics, Inc

NRIX

Nurix Therapeutics Inc

VERA

Vera Therapeutics, Inc

Compare $NRIX vs $VERA

Comparing Nurix Therapeutics Inc and Vera Therapeutics, Inc

NRIXNurix Therapeutics Inc

VERAVera Therapeutics, Inc

NRIXNurix Therapeutics Inc

Market cap

$2.32B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

24.84x

Rev growth (TTM)

-58.4%

YTD performance

23.8%

52W performance

123.9%

FCF yield

-13.1%

VERAVera Therapeutics, Inc

Market cap

$2.14B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

19.87x

Rev growth (TTM)

—

YTD performance

-38.5%

52W performance

-2.0%

FCF yield

-15.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NRIX

VERA

Detailed metrics comparison

NRIX

Nurix Therapeutics Inc

VERA

Vera Therapeutics, Inc

Market Cap

NRIX$2.32B

VERA$2.14B

Enterprise Value

NRIX$2.25B

VERA$2.17B

Price

NRIX$22.35

VERA$29.88

P/E Ratio

NRIXN/A

VERAN/A

P/S Ratio

NRIX63.09x

VERA0.00x

EV/Sales

NRIX61.25x

VERA0.00x

EV/EBITDA

NRIX0.00x

VERA0.00x

P/B Ratio

NRIX5.93x

VERA5.38x

P/FCF Ratio

NRIXN/A

VERAN/A

EV/FCF

NRIX-7.39x

VERA-6.40x

PEG Ratio

NRIXN/A

VERAN/A

Forward P/E (NTM)

NRIXN/A

VERAN/A

Forward P/S (NTM)

NRIX24.84x

VERA19.87x

Revenue (TTM)

NRIX$37M

VERA$0

Revenue Growth (YoY)

NRIX-58.4%

VERAN/A

Forward Rev Growth

NRIX66.6%

VERA698.6%

Gross Margin (TTM)

NRIX0.0%

VERA0.0%

Operating Margin (TTM)

NRIX0.0%

VERA0.0%

EBITDA Margin (TTM)

NRIX-959.0%

VERA0.0%

Net Margin (TTM)

NRIX-928.4%

VERA0.0%

FCF Margin (TTM)

NRIX-828.3%

VERAN/A

Net Income (TTM)

NRIX$-341M

VERA$-402M

FCF (TTM)

NRIX$-305M

VERA$-339M

EPS (TTM)

NRIX-$3.07

VERA-$5.59

ROE (TTM)

NRIX-7609.0%

VERA-8413.0%

ROA (TTM)

NRIX-5732.0%

VERA-6679.0%

ROIC (TTM)

NRIX-7609.0%

VERA-7272.0%

Cash

NRIX$68M

VERA$49M

Debt

NRIX$0

VERA$75M

Net Cash/Debt

NRIX$68M

VERA$-26M

Current Ratio (TTM)

NRIX6.34x

VERA10.92x

Quick Ratio (TTM)

NRIX6.16x

VERA10.50x

Debt/Equity (TTM)

NRIX0.00x

VERA0.18x

Debt/Assets (TTM)

NRIX0.0%

VERA0.0%

Interest Coverage (TTM)

NRIXN/A

VERAN/A

Net Debt/EBITDA (TTM)

NRIX0.00x

VERA0.00x

Beta

NRIX1.78

VERA1.13

52W Performance

NRIX123.9%

VERA-2.0%

YTD Performance

NRIX23.8%

VERA-38.5%

% from 52W High

NRIX-20.8%

VERA-46.7%

% from 52W Low

NRIX148.3%

VERA29.6%

Asset Turnover (TTM)

NRIX0.06x

VERA0.00x

FCF Yield (TTM)

NRIX-13.1%

VERA-15.8%

Earnings Yield (TTM)

NRIX-14.7%

VERA-18.7%

Dividend Yield (TTM)

NRIXN/A

VERAN/A

Rule of 40

NRIX-886.7

VERA0.0

EV/GP/RG

NRIXN/A

VERAN/A

Ticker research

View NRIX research View VERA research

Metric	NRIX Nurix Therapeutics Inc	VERA Vera Therapeutics, Inc
Market & Valuation
Market Cap	$2.32B	$2.14B
Enterprise Value	$2.25B	$2.17B
Price	$22.35	$29.88
P/E Ratio	N/A	N/A
P/S Ratio	63.09x	0.00x
EV/Sales	61.25x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.93x	5.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.39x	-6.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	24.84x	19.87x
Revenue & Growth
Revenue (TTM)	$37M	$0
Revenue Growth (YoY)	-58.4%	N/A
Forward Rev Growth	66.6%	698.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-959.0%	0.0%
Net Margin (TTM)	-928.4%	0.0%
FCF Margin (TTM)	-828.3%	N/A
Net Income (TTM)	$-341M	$-402M
FCF (TTM)	$-305M	$-339M
EPS (TTM)	-$3.07	-$5.59
ROE (TTM)	-7609.0%	-8413.0%
ROA (TTM)	-5732.0%	-6679.0%
ROIC (TTM)	-7609.0%	-7272.0%
Financial Health
Cash	$68M	$49M
Debt	$0	$75M
Net Cash/Debt	$68M	$-26M
Current Ratio (TTM)	6.34x	10.92x
Quick Ratio (TTM)	6.16x	10.50x
Debt/Equity (TTM)	0.00x	0.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.78	1.13
52W Performance	123.9%	-2.0%
YTD Performance	23.8%	-38.5%
% from 52W High	-20.8%	-46.7%
% from 52W Low	148.3%	29.6%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.00x
FCF Yield (TTM)	-13.1%	-15.8%
Earnings Yield (TTM)	-14.7%	-18.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-886.7	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NRIX research	View VERA research

Valuation

P/S Ratio

VERA

0.00x

NRIX

63.09x

EV/FCF

NRIX

-7.39x

VERA

-6.40x

Growth & revenue

Revenue Growth TTM

NRIX

-58.4%

Forward Revenue Growth

VERA

698.6%

NRIX

66.6%

Profitability & performance

Gross Margin

NRIX

0.0%

VERA

0.0%

ROE

NRIX

-7609.0%

VERA

-8413.0%

FCF Yield %

NRIX

-13.1%

VERA

-15.8%

52-Week Performance

NRIX

123.9%

VERA

-2.0%

Detailed metrics comparison

NRIX

Nurix Therapeutics Inc

VERA

Vera Therapeutics, Inc

Market Cap

NRIX$2.32B

VERA$2.14B

Enterprise Value

NRIX$2.25B

VERA$2.17B

Price

NRIX$22.35

VERA$29.88

P/E Ratio

NRIXN/A

VERAN/A

P/S Ratio

NRIX63.09x

VERA0.00x

EV/Sales

NRIX61.25x

VERA0.00x

EV/EBITDA

NRIX0.00x

VERA0.00x

P/B Ratio

NRIX5.93x

VERA5.38x

P/FCF Ratio

NRIXN/A

VERAN/A

EV/FCF

NRIX-7.39x

VERA-6.40x

PEG Ratio

NRIXN/A

VERAN/A

Forward P/E (NTM)

NRIXN/A

VERAN/A

Forward P/S (NTM)

NRIX24.84x

VERA19.87x

Revenue (TTM)

NRIX$37M

VERA$0

Revenue Growth (YoY)

NRIX-58.4%

VERAN/A

Forward Rev Growth

NRIX66.6%

VERA698.6%

Gross Margin (TTM)

NRIX0.0%

VERA0.0%

Operating Margin (TTM)

NRIX0.0%

VERA0.0%

EBITDA Margin (TTM)

NRIX-959.0%

VERA0.0%

Net Margin (TTM)

NRIX-928.4%

VERA0.0%

FCF Margin (TTM)

NRIX-828.3%

VERAN/A

Net Income (TTM)

NRIX$-341M

VERA$-402M

FCF (TTM)

NRIX$-305M

VERA$-339M

EPS (TTM)

NRIX-$3.07

VERA-$5.59

ROE (TTM)

NRIX-7609.0%

VERA-8413.0%

ROA (TTM)

NRIX-5732.0%

VERA-6679.0%

ROIC (TTM)

NRIX-7609.0%

VERA-7272.0%

Cash

NRIX$68M

VERA$49M

Debt

NRIX$0

VERA$75M

Net Cash/Debt

NRIX$68M

VERA$-26M

Current Ratio (TTM)

NRIX6.34x

VERA10.92x

Quick Ratio (TTM)

NRIX6.16x

VERA10.50x

Debt/Equity (TTM)

NRIX0.00x

VERA0.18x

Debt/Assets (TTM)

NRIX0.0%

VERA0.0%

Interest Coverage (TTM)

NRIXN/A

VERAN/A

Net Debt/EBITDA (TTM)

NRIX0.00x

VERA0.00x

Beta

NRIX1.78

VERA1.13

52W Performance

NRIX123.9%

VERA-2.0%

YTD Performance

NRIX23.8%

VERA-38.5%

% from 52W High

NRIX-20.8%

VERA-46.7%

% from 52W Low

NRIX148.3%

VERA29.6%

Asset Turnover (TTM)

NRIX0.06x

VERA0.00x

FCF Yield (TTM)

NRIX-13.1%

VERA-15.8%

Earnings Yield (TTM)

NRIX-14.7%

VERA-18.7%

Dividend Yield (TTM)

NRIXN/A

VERAN/A

Rule of 40

NRIX-886.7

VERA0.0

EV/GP/RG

NRIXN/A

VERAN/A

Ticker research

View NRIX research View VERA research

Metric	NRIX Nurix Therapeutics Inc	VERA Vera Therapeutics, Inc
Market & Valuation
Market Cap	$2.32B	$2.14B
Enterprise Value	$2.25B	$2.17B
Price	$22.35	$29.88
P/E Ratio	N/A	N/A
P/S Ratio	63.09x	0.00x
EV/Sales	61.25x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.93x	5.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.39x	-6.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	24.84x	19.87x
Revenue & Growth
Revenue (TTM)	$37M	$0
Revenue Growth (YoY)	-58.4%	N/A
Forward Rev Growth	66.6%	698.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-959.0%	0.0%
Net Margin (TTM)	-928.4%	0.0%
FCF Margin (TTM)	-828.3%	N/A
Net Income (TTM)	$-341M	$-402M
FCF (TTM)	$-305M	$-339M
EPS (TTM)	-$3.07	-$5.59
ROE (TTM)	-7609.0%	-8413.0%
ROA (TTM)	-5732.0%	-6679.0%
ROIC (TTM)	-7609.0%	-7272.0%
Financial Health
Cash	$68M	$49M
Debt	$0	$75M
Net Cash/Debt	$68M	$-26M
Current Ratio (TTM)	6.34x	10.92x
Quick Ratio (TTM)	6.16x	10.50x
Debt/Equity (TTM)	0.00x	0.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.78	1.13
52W Performance	123.9%	-2.0%
YTD Performance	23.8%	-38.5%
% from 52W High	-20.8%	-46.7%
% from 52W Low	148.3%	29.6%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.00x
FCF Yield (TTM)	-13.1%	-15.8%
Earnings Yield (TTM)	-14.7%	-18.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-886.7	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NRIX research	View VERA research